IP Library Patent Application 18462257
Patent Application
App. No. 18/462,257

PREPARATION AND PURIFICATION METHODS FOR MESENCHYMAL STEM CELL DERIVED SECRETOME

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
18/462,257
Abstract

The present application provides methods and processes for pharmaceutical formulations comprising mesenchymal stem cell secretome for use in ocular treatments, as well as methods for manufacturing and packaging such formulations.

Claims (13)

1 . A method of preparing and packaging a pharmaceutical formulation comprising one or more pharmaceutical agents, the method comprising:

(a) preparing a formulation buffer in a container;

(b) adding and diluting a drug substance preparation comprising one or more pharmaceutical agents in the formulation buffer in the container to generate a first pharmaceutical formulation; and

(c) filling the first formulation to a product container using blow-fill-seal process to generate a second pharmaceutical formulation, wherein the filled product container comprises a therapeutically effective amount of the one or more pharmaceutical agents, and wherein step (c) is performed in an aseptic system.

2 .- 103 . (canceled)

104 . A kit comprising the pharmaceutical formulation of claim 1 .

105 . A kit comprising a pharmaceutical formulation, wherein the pharmaceutical formulation is prepared an packaged into a product container according to claim 1 .

106 . The pharmaceutical formulation of claim 1 , wherein the pharmaceutical formulation is prepared and packaged into a product container according to claim 1 .

107 .- 115 . (canceled)

116 . A method of treating an ocular condition comprising administering the pharmaceutical formulation of claim 1 to a subject in need thereof, wherein the pharmaceutical formulation is prepared and packaged into a product container according to claim 1 .

117 .- 126 . (canceled)

127 . A unit dosage formulation comprising the pharmaceutical formulation of claim 1 .

128 .- 141 . (canceled)

Assignments (2)
SECOND AMENDMENT TO INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Jan 12, 2024
From: COMBANGIO, INC.
To: OXFORD FINANCE LLC
Reel/Frame 066286/0360 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 26, 2023
From: ALFORD, SPENCER; FRANCIS, FELIX SANTHOSH
To: COMBANGIO, INC.
Reel/Frame 065363/0840 →